Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects

Chronobiology International

Volumn 24, Issue 3, 2007, Pages 471-493

  Hermida, Ramón C ^a   Calvo, Carlos ^b   Ayala, Diana E ^a   López, José E ^b   Rodríguez, Marta ^b   Chayán, Luisa ^b   Mojón, Artemio ^a   Fontao, María J ^a   Fernández, José R ^a  

^a UNIVERSITY OF VIGO   (Spain)

^b Hospital Clinico Universitario   (Spain)

Author keywords

Ambulatory blood pressure monitoring; Chronopharmacology; Chronotherapy; Hypertension; Nifedipine GITS

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CHRONOPHARMACOLOGY; CHRONOTHERAPY; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EDEMA; ESSENTIAL HYPERTENSION; FEMALE; GASTROINTESTINAL TRACT; HEADACHE; HUMAN; HYPERTENSION; MALE; MONOTHERAPY; PERIODICITY; RANDOMIZED CONTROLLED TRIAL; RASH; SINGLE DRUG DOSE; SLOW DRUG RELEASE; TREATMENT DURATION; WAKEFULNESS;

ADULT; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CHRONOTHERAPY; CIRCADIAN RHYTHM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; TREATMENT OUTCOME;

EID: 34249307910     PISSN: 07420528     EISSN: 15256073     Source Type: Journal    
DOI: 10.1080/07420520701420683     Document Type: Article

References (60)

1. Anwar YA, Giacco S, McCabe EJ, Tendler BE, White WB. (1998). Evaluation of the efficacy of the Omron HEM-737 Intellisense device for use on adults according to the recommendations of the Association for the Advancement of Medical Instrumentation. Blood Press. Monit. 3:261-265.
2. Baumgart P. (1991). Circadian rhythm of blood pressure: internal and external triggers. Chronobiol. Int. 8:444-450.
3. Caruana MP, Lahiri A, Cashman PM, Altman DG, Raftery EB. (1988). Effects of chronic congestive heart failure secondary to coronary artery disease on the circadian rhythm of blood pressure and heart rate. Am. J. Cardiol. 62:755-759.
4. Defina LF, Bookstaver DA, Goldfinger MP, Coffey TA. (1997). Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring. Ann. Pharmacother. 31:819-822.
5. Fernández JR, Hermida RC. (1998). Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol. Int. 15:191-204.
6. Fernandez JR, Mojón A, Hermida RC. (2004). Comparison of parameters from rhythmometric models with multiple components on hybrid data. Chronobiol. Int. 21:467-482.
7. Fogari R, Malacco E, Tettamanti F, Gnemmi AE, Milani M. (1993). Evening vs. morning isradipine sustained release in essential hypertension: a double-blind study with 24 h ambulatory monitoring. Br. J. Clin. Pharmacol. 35:51-54.
8. Greminger P, Suter PM, Holm D, Kobelt R, Vetter W. (1994). Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. Clin. Invest. 72:864-869.
9. Grundy JS, Foster RT. (1996). The nifedipine gastrointestinal and therapeutic system (GITS): evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. J. Clin. Pharmacokinet. 30:28-51.
10. Guidelines Committee (2003) European Society of Hypertension - European Society of Cardiology guiudelines for the management of arterial hypertension. J. Hypertens. 21:1011-1053.
11. Hansson L, Hedner T, Dahlöf B. (1992). Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Blood Press. 1:113-119.
12. Hermida RC, Ayala DE. (2003). Sampling requirements for ambulatory blood pressure monitoring in the diagnosis of hypertension in pregnancy. Hypertension. 42:619-624.
13. Hermida RC, Smolensky MH. (2004). Chronotherapy of hypertension. Curr. Opin. Nephrol. Hypertens. 13:501-505.
14. Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Calvo C. (2002a). Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol. Int. 19:461-481.
15. Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. (2002b). Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J. Hypertens. 20:1097-1104.
16. Hermida RC, Calvo C, Ayala DE, Fernández JR, Ruilope LM, López JE. (2002c). Evaluation of the extent and duration of the "ABPM effect" in hypertensive patients. J. Am. Coll. Cardiol. 40:710-717.
17. Hermida RC, Ayala DE, Calvo C. (2005). Administration time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr. Opin. Nephrol. Hypertens. 14:453-459.
18. Holm S. (1979). A simple sequentially rejective multiple test procedure. Scand. J. Stat. 6:65-70.
19. Ingelsson E, Björklund-Bodegard K, Lind L, Arnlöv J, Sundström J. (2006). Diurnal blood pressure pattern and risk of congestive heart failure. JAMA. 295:2859-2866.
20. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. (2005). Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality. The Ohasama Study. Hypertension. 45:240-245.
21. Kitahara Y, Saito F, Akao M, Fujita H, Takahashi A, Taguchi H, Hino T, Otsuka Y, Kushiro T, Kanmatsuse K. (2004). Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients. J. Cardiovasc. Pharmacol. 43:68-73.
22. Kohno I, Iwasaki H, Okutani M, Mochizuki Y, Sano S, Satoh Y, Ishihara T, Ishii H, Mukaiyama S, Ijiri H, Komori S, Tamura K. (1997). Administration-time- dependent effects of diltiazem on the 24-hour blood pressure profile of essential hypertension patients. Chronobiol. Int. 14:71-84.
23. Leenen FHH. (1996). Clinical relevance of 24 h blood pressure control by 1,4-dihydropyridines. Am. J. Hypertens. 9:97S-104S.
24. Lemmer B. (1992). Cardiovascular chronobiology and chronopharmacology. In Touitou Y, Haus E (eds.), Biologic rhythms in clinical and laboratory medicine. Berlin, Germany: Springer-Verlag, pp. 418-427.
25. Lemmer B, Nold G, Behne S, Kaiser R. (1991). Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol. Int. 8:485-494.
26. Lemmer B, Lüders S, Schrader J, Manfredini R, Portaluppi F, Nold G, Zuther P. (2003). Chronopharmacology of amlodipine in non-dippers and dippers [abstract]. Naunyn Schmiedebergs Arch Pharmacol. 367(Suppl.1):R113-437.
27. Lubsen J, Wagener G, Kirwan BA, de Brouwer S, Poole-Wilson PA, ACTION investigators. (2005). Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial. J. Hypertens. 23:641-648.
28. Mancia G, Omboni S, Parati G, on behalf of the investigators of the INSIGHT ABPM substudy. (2002). Twenty-four hours ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT). J. Hypertens. 20:545-553.
29. Mansoor GA, White WB, McCabe EJ, Giacco S. (2000). The relationship of electronically monitored physical activity to blood pressure, heart rate, and the circadian blood pressure profile. Am. J. Hypertens. 13:262-267.
30. Meilhac B, Mallion JM, Carre A, Chanudet X, Poggi L, Gosse P, Dallocchio M. (1992). Study of the influence of the time of administration on the antihypertensive effect and nitrendipine tolerance in mild to moderate essential hypertensive patients. Value of ambulatory recording of blood pressure on 24 hours. Therapie. 47:205-210.
31. Mengden T, Binswanger B, Gruene S. (1992). Dynamics of drug compliance and 24-hour blood pressure control of once daily morning vs. evening amlodipine. J. Hypertens. 10(Suppl.4):S136.
32. Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, Berman L, Shi H, Buebendorf E, Topol EJ. (2004). Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA. 292:2217-2225.
33. Nold G, Strobel G, Lemmer B. (1998). Morning vs. evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press. Monit. 3:17-25.
34. O'Brien E, Staessen J. (1995). Normotension and hypertension as defined by 24-hour ambulatory blood pressure monitoring. Blood Press. 4:266-282.
35. O'Brien E, Sheridan J, O'Malley K. (1988). Dippers and non-dippers. Lancet. 13:397.
36. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P. on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. (2003). European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J. Hypertens. 21:821-848.
37. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. (2002). Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20:2183-2189.
38. Pickering TG. (1990). The clinical significance of diurnal blood pressure variations: dippers and nondippers. Circulation. 81:700-702.
39. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. (2005). Recommendations for blood pressure measurement in humans and experimental animals, Part 1: Blood pressure measurement in humans. Hypertension. 45:142-161.
40. Poole-Wilson PA, Lubsen J, Kirwan BA, van Dalen FJ, Wagener G, Danchin N, Just H, Fox KA, Pocock SJ, Clayton TC, Motro M, Parker JD, Bourassa MG, Dart AM, Hildebrandt P, Hjalmarson A, Kragten JA, Molhoek GP, Otterstad JE, Seabra-Gomes R, Soler-Soler J, Weber S. (2004). Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomized controlled trial. Lancet. 364:849-857.
41. Portaluppi F, Smolensky MH. (2000). Circadian rhythm and environmental determinants of blood pressure regulation in normal and hypertensive conditions. In White WB (ed.), In blood pressure monitoring in cardiovascular medicine and therapeutics. Totowa, NJ: Humana Press, pp. 79-118.
42. Portaluppi F, Montanari L, Ferlini M, Vergnani L, Bagni B, Degli Uberti EC. (1992). Differences in blood pressure regulation of congestive heart failure, before and after treatment, correlate with changes in the circulating pattern of atrial natriuretic peptide. Eur. Heart J. 13:990-996.
43. Portaluppi F, Vergnani L, Manfredini R, Degli Uberti EC, Fersini C. (1995). Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am. J. Hypertens. 8:719-726.
44. Qiu YG, Chen JZ, Zhu JH, Yao XY. (2003). Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate. Cardiovasc. Drugs Ther. 17:335-341.
45. Seki S, Taniguchi M, Ohsawa S, Koga A, Ito T, Kunoh M, Imamoto S, Miyazaki H, Takeda S, Iwano K, Satoh C, Kanae K, Mochizuki S. (2005). Chronobiological analysis by ambulatory blood pressure monitoring of the hyperbaric and hypobaric indexes for evaluation of the antihypertensive effect of long-acting nifedipine. Circ. J. 69:1249-1255.
46. Shimada K, Kario K. (1997). Altered circadian rhythm of blood pressure and cerebrovascular damage. Blood Press. Monit. 2:333-338.
47. Sica DA, Wilson DK. (2000). Sodium, potassium, the sympathetic nervous system, and the reninangiotensin system: impact on the circadian variability in blood pressure. In White WB (ed.), Blood pressure monitoring in cardiovascular medicine and therapeutics. Totowa, NJ: Humana Press, pp. 171-190.
48. Smith DH, Neutel JM, Lacourciere Y, Kempthorne-Rawson J. (2003). Prospective, randomized, openlabel, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements. J. Hypertens. 21:1291-1298.
49. Staessen J, Fagard R, Lijnen P, Thijs L, Vaa Hoof R, Amery A. (1991). Ambulatory blood pressure monitoring in clinical trials. J. Hypertens. 9(Suppl.1):S13-S19.
50. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, ÓBrien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A. (1997). Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet. 350:757-764.
51. Staessen JA, Thijs L, Fagard R, ÓBrien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J, for the Systolic Hypertension in Europe (Syst-Eur) Trial investigators. (1999). Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. JAMA 282:539-546.
52. Suzuki Y, Kuwajima I, Kanemaru A, Shimosawa T, Hoshino S, Sakai M, Matsushita S, Ueda K, Kuramoto K. (1992). The cardiac functional reserve in elderly hypertensive patients with abnormal diurnal change in blood pressure. J. Hypertens. 10:173-179.
53. Timio M, Venanzi S, Lolli S, Lippi G, Verdura C, Monarca C, Guerrini E. (1995). "Non-dipper" hypertensive patients and progressive renal insufficiency: a three-year longitudinal study. Clin. Nephrol. 43:382-387.
54. Toal CB. (2004). Formulation dependent pharmacokinetics - does the dosage form matter for nifedipine? J. Cardiovasc. Pharmacol. 44:82-86.
55. Touitou Y, Smolensky MH, Portaluppi F. (2006). Ethics, standards and procedures of animal and human chronobiology research. Chronobiol. Int. 23:1083-1096.
56. Umeda T, Naomi S, Iwaoka T, Inoue J, Sasaki M, Ideguchi Y, Sato T. (1994). Timing for administration of an antihypertensive drug in the treatment of essential hypertension. Hypertension. 23(Suppl. 1):I211-I214.
57. van de Borne P, Abramowicz M, Degre S, Degaute JP. (1992). Effects of chronic congestive heart failure on 24-hour blood pressure and heart rate patterns: a hemodynamic approach. Am. Heart J. 123:998-1004.
58. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. (1994). Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 24:793-801.
59. White WB, Mansoor GA, Pickering TG, Vidt DG, Hutchinson HG, Johnson RB, Noveck R. (1999). Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am. J. Hypertens. 12:806-814.
60. Zanchetti A. (1994). Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group. J. Hypertens. 12(Suppl. 5):S23-S27.